跳至主要内容
临床试验/CTRI/2023/10/058587
CTRI/2023/10/058587尚未招募1/2 期

A Clinical Study of Dushivisaari Agad and Ark Tail in Vicharchika (Atopic dermatitis).

POST GRADUATE INSTITUTE OF AYURVED JODHPUR1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年10月18日最近更新:

试验速览

阶段
1/2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
LFT

研究概览

简要总结

STUDY DESIGN

·      Typesof study       - Openlabelled clinical trial with single group.

·      Level of study         - O.P.D. & I.P.D. UPGIAS&R, DSRRAU JODHPUR and other   registeredhospital

·      Number of groups   -  One

·      Sample size             -   30

·      Primary purpose      -  Efficacy and safety

·       End point                - Therapy

DRUGAND POSOLOGY

Patient

30

Treatment Modality

Dose

Duration

|Dushivisaari Agad

3gms BD with honey

30 Days

|Ark  Tail

For local application.

30 Days

FOLLOW UP STUDY

·      After completion of thetrial, the case will be followed every 15 days interval for 30 days.

·       Improvement and other effect will be noted.

·      Laboratoryinvestigations will be repeated if seemed necessary

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • 1.Diagnosed Patient complaints having itching,.
  • 2.Age between 18-50 year.
  • 3.Patient willing to give consent for clinical trial.

排除标准

  • 1.Endocrine disorder like diabetes mallitus, thyroid disfunction.
  • 2.Age- below18 years and above 50 years.
  • 3.patients who are suffering from major psychiatric disorder.

结局指标

主要结局

LFT

时间窗: 30 days

Improvement in the values of following data

时间窗: 30 days

CBC

时间窗: 30 days

blood sugar random

时间窗: 30 days

ESR

时间窗: 30 days

KFT

时间窗: 30 days

次要结局

  • improvement in sign & symptoms like Kandu (itching)(Srava (discharge))

研究者

发起方
POST GRADUATE INSTITUTE OF AYURVED JODHPUR
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验